Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 175, Issue 5, Pages 868-875
Publisher
Wiley
Online
2016-09-10
DOI
10.1111/bjh.14317
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale
- (2014) A. Gallamini et al. HAEMATOLOGICA
- Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy
- (2014) Koichi Yanaba et al. International Journal of Rheumatic Diseases
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- In Vivo Treatment Sensitivity Testing With Positron Emission Tomography/Computed Tomography After One Cycle of Chemotherapy for Hodgkin Lymphoma
- (2014) Martin Hutchings et al. JOURNAL OF CLINICAL ONCOLOGY
- Omitting Radiotherapy in Early Positron Emission Tomography–Negative Stage I/II Hodgkin Lymphoma Is Associated With an Increased Risk of Early Relapse: Clinical Results of the Preplanned Interim Analysis of the Randomized EORTC/LYSA/FIL H10 Trial
- (2014) John M.M. Raemaekers et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
- (2014) Bruce D. Cheson et al. JOURNAL OF CLINICAL ONCOLOGY
- Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis
- (2014) Morten Stilund et al. PLoS One
- Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma
- (2013) J. Ouyang et al. BLOOD
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma
- (2013) P. R. Marri et al. CLINICAL CANCER RESEARCH
- FDG-PET Response–adapted Therapy
- (2013) Martin Hutchings HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Altered galectin-1 serum levels in patients diagnosed with high-grade glioma
- (2013) Tina Verschuere et al. JOURNAL OF NEURO-ONCOLOGY
- The Macrophage-Specific Serum Marker, Soluble CD163, Is Increased in Obesity and Reduced After Dietary-Induced Weight Loss
- (2013) Karen Fjeldborg et al. Obesity
- The microenvironment in classical Hodgkin lymphoma: An actively shaped and essential tumor component
- (2013) Yuxuan Liu et al. SEMINARS IN CANCER BIOLOGY
- Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management
- (2012) Stephen M. Ansell AMERICAN JOURNAL OF HEMATOLOGY
- Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma
- (2012) Maike Sauer et al. AMERICAN JOURNAL OF HEMATOLOGY
- Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma
- (2012) K. Jones et al. CLINICAL CANCER RESEARCH
- Hodgkin lymphoma
- (2012) Ralf Küppers et al. JOURNAL OF CLINICAL INVESTIGATION
- Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma
- (2011) W. J. Plattel et al. HAEMATOLOGICA
- Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22
- (2008) Marijke Niens et al. BRITISH JOURNAL OF HAEMATOLOGY
- Serum Galectin-1 and Galectin-3 Levels in Benign and Malignant Nodular Thyroid Disease
- (2008) Sven Saussez et al. THYROID
- The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy
- (2007) Sven Saussez et al. ORAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now